Actos and its link to bladder cancer discussed by Beasley Allen attorney Andy Birchfield

This week on the Beasley Allen Report, host Gibson Vance welcomes Beasley Allen lawyer Andy Birchfield. Birchfield is head of Beasley Allen’s Mass Torts section, which is currently working on cases involving the drug Actos and its link to bladder cancer. Actos, manufactured by Takeda Pharmaceuticals, was issued a warning by the FDA saying people who have been taking the drug for a year or longer have an increased risk of developing bladder cancer. Interim results from a 10-year American study found long-term Actos users had 40 percent more bladder cancers than people who never took the drug. Bladder cancer kills about 15,000 people per year in the U.S. The drug also may be linked to congestive heart failure.

To learn more about Actos and its deadly side-effects, please visit our Actos website at http://www.actos-claim.com/.


We're here to help!

We live by our creed of “helping those who need it most” and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked * may be required for submission.


Best for clients

Great firm. Supports the community. They want what is best for their clients.

—Jennifer